| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Opioids represent a large class of medications commonly used to relieve acute and chronic pain or to help manage opioid abuse and dependence. These medications can produce physical and psychological dependence and have a high risk for abuse and diversion. As a result, many professional practice guidelines recommend compliance testing in patients who are prescribed these medications.
Opioid test menu
Our targeted, high-resolution mass spectrometry screening assay does not hydrolyze the urine sample, allowing for both the parent and metabolites of 33 different opioids to be detected. Results of this assay enable clinicians to accurately detect opioid use and effectively monitor treatment compliance.
Key testing
Highlights
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.
Several of our comprehensive profiles include targeted opioid screening (Mayo ID: TOPSU).
Panel testing
Key testing